Every claim we hold, and how far we can stand behind it.
142 claims across 39 products. 28% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.
| Evidence class | Claims | Confirmed | What it can support |
|---|---|---|---|
| Peer-reviewed study | 19 | 5 | Reviewed before publication; assess study quality, funding, conflicts, and relevance to your setting. |
| Regulatory filing | 4 | 0 | A statement made to a regulator, where being wrong has consequences. |
| Independent report | 32 | 9 | Reporting outside a vendor publication; assess underlying data, sponsorship, and conflicts separately. |
| Customer case | 4 | 3 | A real deployment, but selected and framed by someone with an interest. |
| Press release | 63 | 22 | The vendor's own announcement. Useful for dates and facts, not for outcomes. |
| Vendor page | 20 | 1 | Marketing copy. Establishes what is claimed, never that it is true. |
Showing 4 of 4 matching claims (142 in the full corpus) · 0% of this selection is confirmed · clear filters
Waystar reported Q2 2026 revenue of $319.7M (+18% YoY) and raised its FY2026 guidance; over a dozen clients committed to its new AI anomaly detection solution with early adopters recovering ~$3M incremental revenue per 10,000 admissions, and Iodine cross-sell generated $6M+ in bookings.
Provenance
- Claim ID
- clm_7f95eed1874010db1d78
- Version
- 1
- Workflow
- Revenue Cycle / Coding / Prior Auth
- Dimension
- economic value
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://www.fiercehealthcare.com/finance/waystar-boosts-2026-outlook-after-solid-q2-performance
CB Insights profiled Adonis among prior-auth platforms gaining from CMS-0057-F electronic prior authorization deadline (Jan 2027).
Provenance
- Claim ID
- clm_afc63b6f42d2382346f1
- Version
- 1
- Workflow
- Revenue Cycle / Coding / Prior Auth
- Dimension
- deployment traction
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://www.cbinsights.com/research/report/digital-health-trends-q1-2026/
Raised an $80M Series A, which CB Insights' Q1'26 report cites as a prior-authorization pure-play deal as the CMS-0057-F deadline redirects investment.
Provenance
- Claim ID
- clm_07cce2a710060b719613
- Version
- 2
- Workflow
- Revenue Cycle / Coding / Prior Auth
- Dimension
- market durability
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://www.cbinsights.com/research/report/digital-health-trends-q1-2026/
TechTarget RevCycleManagement (Mar 26, 2026) reports Adonis raised a $40M Series C led by Quadrille Capital, bringing total funding to $95M; the company reported four times revenue growth and net retention above 130%, and names Mount Sinai Health System among partnering organisations.
Provenance
- Claim ID
- clm_08a8778277b3e52cbf76
- Version
- 1
- Workflow
- Revenue Cycle / Coding / Prior Auth
- Dimension
- market durability
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://www.techtarget.com/revcyclemanagement/news/366640740/Adonis-raises-40M-to-accelerate-AI-in-revenue-cycle